Products

Active Pharmaceutical Ingredients

No. PRODUCT STANDARDS END USE CAS
1 CILNIDIPINE IP/JP/IH ANTI-HYPERTENSIVE 132203-70-4
2 BENIDIPINE HCl JP/IH ANTI-HYPERTENSIVE 91599-74-5
3 AZELNIDIPINE JP/IP/IH ANTI-HYPERTENSIVE 123524-52-7
4 IRON SUCROSE IH HAEMATINIC 8047-67-4
5 TORSEMIDE IP/USP/BP DIURECTIC 56211-40-6
6 FEBANTEL IP/EP/BP ANTHELMINTIC 58306-30-2
8 TAMSULOSIN HCl IP/BP/USP DIFFICULT URINATION 106463-17-6
9 FINASTERIDE IP/USP/EP DIFFICULT URINATION 98319-26-7
10 DUTASTERIDE IP/USP DIFFICULT URINATION 164656-23-9
11 LAFUTIDINE IH ANTI SECRETORY 118288-08-7
12 PRAZIQUANTEL IP/USP/BP/EP ANTHELMINTIC 55268-74-1
13 CILOSTAZOL USP ANTI-HYPERTENSIVE 73963-72-1
14 LORNOXICAM IH ARTHRITIS 70374-39-9
15 FEBUXOSTAT (FORM A,B) IH GOUT 144060-53-7
16 BOSENTAN MONOHYDRATE IH ANTI HYPERTENSIVE 157212-55-0
17 BUPROPION HCl USP SMOKING CESSATION 31677-93-7
18 NEPAFENAC IH OPHTHALMIC NSAID 78281-72-8
19 LOTEPREDNOL ETABONATE IH OPHTHALMIC STEROID 82034-46-6
20 CETILISTAT IH OBESITY 282526-98-1
21 PRUCALOPRIDE SUCCINATE IH INTESTINAL DISORDER 179474-85-2
  UNDER DEVELOPMENT      
22 FIMASARTAN KA TRIHYDRATE IH ANTI HYPERTENSIVE 1020110-23-9

API Intermediates

Sr. No. Intermediates CAS END USE
1 2-Cyanoacetic acid-1-(diphenylmethyl)-3-azetidinyl ester 116574-14-2 Azelnidipine
2 Isopropyl-2-(3-nitrobenzylidene)acetoacetate 39562-25-9
3 3-Amino-3-iminopropanoic acid-1-(diphenylmethyl)-3-azetidinyl ester acetate 170749-59-4
4 1-Benzyl piperidin-3-ol 14813-01-5 Benidipine
5 2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)- 1,4-dihydropyridine-3-carboxylic acid 74936-72-4
6 2-methoxyethyl-2-(3-nitrobenzyledene) Acetoacetate 39562-22-6 Cilnidipine
7 3-Amino crotonic acid cinnamyl ester 103909-86-0
8 2-methoxy-N-[2-nitro-5-(phenylthio)phenyl] Acetamide 63470-85-9 Febantel
9 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone 54197-66-9 Cilostazol
Products protected by valid patents are not offered for sale in countries where the sale of such products constitute a patent infringement.